Stewarding the Soul of MGH
The LVC is one of the oldest hospital volunteer auxiliaries in the country. Now marking its 155th anniversary, the group began in 1869 as the Ladies Visiting Committee.
29th Annual Summer Course:
Current Techniques in Molecular Genetics 2019
Monday, July 15 through Friday, July 26
Massachusetts General Hospital, Main Campus, 55 Fruit Street
O'Keefe Auditorium
Hans-Christian Reinecker, Course Director
Dietary control of stem cells in physiology and disease
Omer Yilmaz | Monday, July 15 | 8:30 am |
Gut-liver-brain physiomimetics for the multimic studies of acute and chronic inflammation
Martin Trapecar | Monday, July 15 | 9:30 am |
Single-cell genomic approaches for understanding human barrier tissue dysfunction
Jose Ordovas-Montanes | Wednesday, July 17 | 8:30 am |
Detection of protein expression by immnocytochemistry
Sylvie Breton | Wednesday, July 17 | 9:30 am |
Gene discovery
Mark Daly | Friday, July 19 | 8:30 am |
Understanding human health and disease at the single-cell level
Orr Ashenberg | Friday, July 19 | 9:30 am |
Improving efficiency of CRISPR/Cas9-mediated genome editing in mice
Lin Wu | Monday, July 22 | 8:30 am |
Structure, function and detection of noncoding RNAs
Alan Mullen | Monday, July 22 | 9:30 am |
Advances in CRISPR genome editing for the modeling and treatment of disease
Benjamin Kleinstiver | Wednesday, July 24 | 8:30 am |
Epigenetics 101: Basic theory and lab techniques
Kate Jeffrey | Wednesday, July 24 | 9:30 am |
Multi'omics for the human microbiome
Curtis Huttenhower | Friday, July 26 | 8:30 am |
Towards the treatment of inflammatory bowel disease via rational manipulation of the gut microbiome
Brantley Hall | Friday, July 26 | 9:30 am |
The LVC is one of the oldest hospital volunteer auxiliaries in the country. Now marking its 155th anniversary, the group began in 1869 as the Ladies Visiting Committee.
Mass General Brigham clinicians, caregivers, and staff are coming together like never before to work to become the integrated academic healthcare system of the future with patients at the center.
In this interview with Targeted Oncology, Matthew Frigault, MD discusses follow-up data on the efficacy and safety of CART-ddBCMA for the treatment of patients with relapsed/refractory multiple myeloma, particularly in later-line settings.
In this podcast, Kristen Mahoney Shannon, MS, CGC discusses what people should know about their hereditary breast cancer risk, including how to know if it runs in your family and what to expect during genetic counseling.
Support groups can help address the psychosocial needs of AYA patients and offer an important outlet during treatment.
Through the Adolescent and Young Adult Cancer Program at Mass General Cancer Center, Grace was able to connect with other people her age grappling with similar diagnoses.